All these results suggest that active TNF‐α signalling is a universal phenomenon among polyps, indicating that the use of anti‐TNF therapy might be an alternative strategy to reduce the recurrence of polyps in JPS, PJS and SJP paediatric patients with coagulation disorders or unstable vital signs who are not unsuitable for polypectomy. Here, TNF is linked to blood coagulation disease.